LEDERMAN SETH 4

What Happened

• Seth Lederman, CEO of Tonix Pharmaceuticals Holding Corp. (TNXP), purchased 5,000 shares in open-market transactions on 2026-03-31. The weighted average purchase price was $12.62 per share, for a total cost of approximately $63,100. The transaction is reported as a purchase (code P).

Key Details

• Transaction date: 2026-03-31; Form 4 filed: 2026-04-01 (filed promptly the next day).
• Price: weighted average $12.62/share; price range reported in footnote F1: $12.5699–$12.625 per share.
• Amount: 5,000 shares; total approximately $63,100.
• Transaction type: Open-market purchase (code P).
• Shares owned after transaction: Not specified in this Form 4 filing.
• Footnotes: F1 explains the weighted-average price and offers to provide per-trade prices on request; F2 notes the reporting person may be deemed a control person of the entity.
• No 10b5-1 plan, option exercise, or tax-withholding event disclosed in this filing.

Context

• This was a straightforward open-market purchase (not an option exercise or gift). Insider purchases are commonly watched by investors as potentially informative, but the filing does not state Lederman’s reason for buying.